Oncoimmunology
Oncoimmunology
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
1360
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 1360 PapersA bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity.
Albu DI, Wolf BJ, Qin Y, Wang X, Daniel Ulumben A, Su M, Li V, Ding E, Angel Gonzalo J, Kong J, Jad…
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes.
Ying L, Hu Z, Lu Y, Tao Q, Xiong F, Shu Y, Yang Y, Qiao X, Peng C, Jiang Y, Han M, Xu M, Li X, Wang…
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Glöckner HJ, Martinenaite E, Landkildehus Lisle T, Grauslund J, Ahmad S, Met Ö, Thor Straten P, Hal…
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8<sup>+</sup>T cell function and its impact …
Wei W, Tian L, Zheng X, Zhong L, Chen Y, Dong H, Zhang G, Wang S, Tong X.
Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell…
Ramil CP, Xiang H, Zhang P, Cronin A, Cabral L, Yin Z, Hai J, Wang H, Ruprecht B, Jia Y, Sun D, Che…
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function.
Fenaux J, Fang X, Huang YM, Melero C, Bonnans C, Lowe EL, Palumbo T, Lay C, Yi Z, Zhou A, Poggio M,…
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8<sup>+</sup> T cells towards the ce…
Brownlie D, von Kries A, Valenzano G, Wild N, Yilmaz E, Säfholm J, Al-Ameri M, Alici E, Ljunggren H…
A Chemically Defined TLR3 Agonist with Anticancer Activity.
Le Naour J, Thierry S, Scuderi SA, Boucard-Jourdin M, Liu P, Bonnin M, Pan Y, Perret C, Zhao L, Mao…
Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant meta…
Tang WF, Fan XJ, Bao H, Fu R, Liang Y, Wu M, Zhang C, Zhang C, Su J, Wu YL, Zhong WZ.
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer.
Poinot H, Dupuychaffray E, Arnoux G, Alvarez M, Tachet J, Ezzar O, Moore J, Bejuy O, Olesti E, Visc…